Aicee D. Calma
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis.
Journal: Journal of neurology
Published: June 23, 2026
Integration of Serum Neurofilament Light Chain and Cortical Dysfunction Improves Diagnostic Accuracy in ALS.
Journal: Annals of clinical and translational neurology
Published: May 04, 2026
Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: December 26, 2025
Utility of Far-Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy.
Journal: Muscle & nerve
Published: November 27, 2025
Neck flexion weakness predicts respiratory dysfunction in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 11, 2025
The evolving landscape of spinal muscular atrophy treatment.
Journal: The Lancet. Neurology
Published: July 08, 2025
Clinical Utility of Far-Field Potentials in Amyotrophic Lateral Sclerosis.
Journal: Muscle & nerve
Published: April 24, 2025
Cerebral venous sinus thrombosis after intrathecal administration of nusinersen.
Journal: BMJ case reports
Published: January 04, 2025
Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: December 17, 2024
Utility of Cortical Inhibitory and Facilitatory Neuronal Circuits in Amyotrophic Lateral Sclerosis Diagnosis.
Journal: European journal of neurology
Published: November 21, 2024
Somatosensory evoked potentials: technique, interpretation and clinical applications.
Journal: Practical neurology
Published: November 03, 2024
Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 07, 2024
Last Updated: 09/26/2026